Sorafenib and dehydration Patient Reports February 10, 2012
Sorafenib Side Effects Report #5625706-8
Sorafenib side effect was reported by a Physician from GERMANY on Feb 06, 2008. Female patient, 56 years of age, weighting 176.4 lb, was diagnosed with renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dehydration, disturbance in attention, dyspnoea, fatigue, oedema peripheral, pleural effusion, pulmonary embolism
. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with TORSEMIDE, PANTOPRAZOL, HYDROXYMORPHIN, CIPRAMIL, FLUNITRAZEPAM. Patient was hospitalized. Patient died on 12/26/2007.Sorafenib Side Effects Report #5625689-0
Sorafenib side effect was reported by a Health Professional from UNITED STATES on Feb 05, 2008. Male patient, 73 years of age, was diagnosed with prostate cancer
and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dehydration, fatigue, hypocalcaemia. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with DOCETAXEL, MOTRIN, FENTANYL, TYLENOL W, LUPRON, PREDNISONE, VITAMIN CAP. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5678577-8
Sorafenib side effect was reported by a Health Professional from UNITED STATES on Mar 13, 2008. Male patient, 73 years of age, was diagnosed with prostate cancer
and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: abdominal pain
, blood chloride decreased, blood potassium decreased, blood sodium decreased, dehydration, electrolyte imbalance, fatigue, hypocalcaemia, nausea
. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with DOCETAXEL, MOTRIN, FENTANYL, TYLENOL W, LUPRON, PREDNISONE, VITAMIN CAP, DURAGESIC. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5622846-4
Sorafenib side effect was reported by a Health Professional from UNITED STATES on Feb 08, 2008. Male patient was diagnosed with prostate cancer
and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dehydration, fatigue, hypocalcaemia. Sorafenib dosage: 400MG BID PO. During the same period patient was treated with DOCETAXEL, MOTRIN, FENTANYL TRANSDERMAL SYSTEM, TYLENOL, LUPRON, PREDNISONE, VITAMIN CAP. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5670252-9
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 14, 2008. Male patient was diagnosed with prostate cancer
and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: abdominal pain
, dehydration, electrolyte imbalance, fatigue, nausea
. Sorafenib dosage: 400 MG BID PO. During the same period patient was treated with DOCETAXEL, MOTRIN, FENTANYL TRANSDERMAL SYSTEM, TYLENOL, LUPRON, PREDNISONE, VITAMIN CAP. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5907627-6
Sorafenib side effect was reported by a Health Professional from UNITED STATES on Oct 02, 2008. Male patient, weighting 239.6 lb, was diagnosed with prostate cancer
and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: clostridium difficile colitis, dehydration. Sorafenib dosage: 200MG QD PO. During the same period patient was treated with OMEPRAZOLE, METOPROLOL TARTRATE, DECADRON, REGLAN, LUPRON, ZANTAC, PROVENTIL, BENAZEPRIL HYDROCHLORIDE. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5944369-5
Sorafenib side effect was reported by a Health Professional from UNITED STATES on Nov 06, 2008. Male patient, weighting 239.6 lb, was diagnosed with prostate cancer
and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: clostridial infection, dehydration, diarrhoea. Sorafenib dosage: 200 MG QD PO. During the same period patient was treated with OMEPRAZOLE, LUPRON, COUMADIN, METOPROLOL TARTRATE, ZANTAC, COMPAZINE, DECADRON, PROVENTIL. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5780075-8
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on June 13, 2008. Male patient, 66 years of age, weighting 229.3 lb, was diagnosed with pancreatic carcinoma, hypertension, mineral supplementation, insomnia, constipation
, gastrooesophageal reflux disease and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: abdominal pain
, dehydration, lobar pneumonia, nausea
. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with GEMCITABINE, METOPROLOL SUCCINATE, ZOLPIDEM, LUNESTA, DOCUSATE, NEXIUM. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #6099404-3
Sorafenib side effect was reported by a Health Professional from UNITED STATES on Feb 26, 2009. Male patient, weighting 211.2 lb, was diagnosed with pancreatic carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dehydration, disease progression, gastroenteritis
, pseudocyst. Sorafenib dosage: 400 MG PO BID. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5566269-5
Sorafenib side effect was reported by a Physician from UNITED STATES on Dec 06, 2007. Male patient, 68 years of age, weighting 143.3 lb, was diagnosed with oesophageal carcinoma, pain in extremity, hiatus hernia, prophylaxis against diarrhoea, bone disorder and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dehydration, fatigue, mucosal inflammation. Sorafenib dosage: unknown. During the same period patient was treated with DOCETAXEL, NEURONTIN, PRILOSEC, SENNA S, ZOMETA. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5649447-6
Sorafenib side effect was reported by a Physician from BRAZIL on Sept 06, 2007. Female patient, 81 years of age, weighting 121.3 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: anaemia, anorexia, constipation
, dehydration, neutropenia, pain in extremity, subcutaneous nodule, thrombocytopenia, vomiting. Sorafenib dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5202147-9
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 08, 2007. Male patient, 63 years of age, weighting 127.9 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: abdominal pain
, blood alkaline phosphatase increased, confusional state, constipation
, decreased appetite, dehydration, disease progression, gamma-glutamyltransferase increased, tremor. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with COMPAZINE, OXYCONTIN, OXYCODONE. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5205717-7
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 08, 2007. Male patient, 63 years of age, weighting 127.9 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: abdominal pain
, blood alkaline phosphatase increased, confusional state, constipation
, dehydration, gamma-glutamyltransferase increased, tremor. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with COMPAZINE, OXYCONTIN, OXYCODONE. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5210307-6
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 09, 2007. Male patient, 63 years of age, weighting 127.9 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: abdominal pain
, blood alkaline phosphatase increased, confusional state, constipation
, dehydration, gamma-glutamyltransferase increased, tremor. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with COMPAZINE, OXYCONTIN, OXYCODONE, WELLBUTRIN, CELEXA, LORAZEPAM. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5232277-7
Sorafenib side effect was reported by a Physician from UNITED STATES on Feb 05, 2007. Male patient, 63 years of age, weighting 127.9 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: abdominal pain
, blood alkaline phosphatase increased, confusional state, constipation
, dehydration, gamma-glutamyltransferase increased, pneumonia
, tremor. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with COMPAZINE, OXYCONTIN, OXYCODONE, WELLBUTRIN. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5376933-9
Sorafenib side effect was reported by a Physician from UNITED STATES on June 18, 2007. Male patient, 63 years of age, weighting 141.1 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dehydration, oesophagitis. Sorafenib dosage: TOTAL DAILY DOSE: 200 MG UNIT DOSE: 200 MG. During the same period patient was treated with CISPLATIN, ETOPOSIDE. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5281478-0
Sorafenib side effect was reported by a Physician from UNITED STATES on Mar 20, 2007. Female patient, 62 years of age, weighting 116.8 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: anorexia, dehydration, fatigue, hypocalcaemia, hypophosphataemia, lymphopenia, nausea
, pancreatitis, rash
. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5293146-X
Sorafenib side effect was reported by a Physician from UNITED STATES on Apr 03, 2007. Female patient, 62 years of age, weighting 116.8 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: anorexia, dehydration, fatigue, hypocalcaemia, hypophosphataemia, lymphopenia, nausea
, pancreatitis. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5295843-9
Sorafenib side effect was reported by a Physician from UNITED STATES on Apr 11, 2007. Female patient, 62 years of age, weighting 116.8 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: anorexia, dehydration, disease progression, fatigue, hypocalcaemia, hypophosphataemia, lymphopenia, nausea
, non-small cell lung cancer. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. Patient was hospitalized. Patient died on 04/04/2007.Sorafenib Side Effects Report #5423602-2
Sorafenib side effect was reported by a Physician from UNITED STATES on Aug 22, 2007. Female patient, 62 years of age, weighting 116.8 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: anorexia, dehydration, fatigue, hypocalcaemia, hypophosphataemia, lymphopenia, nausea
, non-small cell lung cancer, pancreatitis. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. Patient was hospitalized. Patient died on 04/04/2007.Sorafenib Side Effects Report #5021020-2
Sorafenib side effect was reported by a Physician from UNITED STATES on May 19, 2006. Male patient, 61 years of age, weighting 242.5 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: ascites, blood electrolytes abnormal, dehydration, disease progression, dyspnoea, electrocardiogram qt corrected interval prolonged, hyperkalaemia, hyponatraemia, hypotension. Sorafenib dosage: 400 MG, BID; ORAL. During the same period patient was treated with ALEVE, AMBIEN, COMPAZINE, CASANTHRANOL W, LACTULOSE, OXYCODONE, PEPCID. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5032088-1
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on May 26, 2006. Male patient, 61 years of age, weighting 242.5 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: ascites, blood creatinine increased, blood electrolytes abnormal, dehydration, disease progression, dyspnoea, electrocardiogram qt corrected interval prolonged, hyperkalaemia, hyponatraemia. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with ALEVE, AMBIEN, COMPAZINE, LACTULOSE, OXYCODONE, PEPCID, TUMS. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5649436-1
Sorafenib side effect was reported by a Physician from GERMANY on Feb 20, 2008. Male patient, 56 years of age, weighting 99.21 lb, was diagnosed with non-small cell lung cancer, medical diet and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: cardiac failure congestive, dehydration, lung neoplasm malignant, renal failure, respiratory failure, sepsis
, sinus tachycardia, thrombocytopenia. Sorafenib dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 200 MG. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, FISH OIL, ESTER C. Patient was hospitalized. Patient died on 08/15/2006.Sorafenib Side Effects Report #5669808-9
Sorafenib side effect was reported by a Physician from GERMANY on Mar 11, 2008. Male patient, 56 years of age, weighting 99.21 lb, was diagnosed with non-small cell lung cancer, medical diet and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: cardiac failure congestive, dehydration, lung neoplasm malignant, renal failure, respiratory failure, sepsis
, sinus tachycardia, thrombocytopenia. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, FISH OIL, ESTER C. Patient was hospitalized. Patient died on 08/15/2006.Sorafenib Side Effects Report #5728310-6
Sorafenib side effect was reported by a Physician from UNITED STATES on Apr 18, 2008. Male patient, 56 years of age, weighting 99.21 lb, was diagnosed with non-small cell lung cancer, medical diet and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: cardiac failure congestive, dehydration, lung neoplasm malignant, renal failure, respiratory failure, sepsis
, sinus tachycardia, thrombocytopenia. Sorafenib dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 200 MG. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, FISH OIL, ESTER C. Patient was hospitalized. Patient died on 08/15/2006.Sorafenib Side Effects Report #6052771-9
Sorafenib side effect was reported by a Physician from GERMANY on Jan 22, 2009. Male patient, 56 years of age, weighting 191.8 lb, was diagnosed with non-small cell lung cancer, hypertension, prophylaxis, nausea
, mucosal inflammation, nasal dryness and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: circulatory collapse, dehydration, diarrhoea. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with CISPLATIN, GEMCITABINE, BLOPRESS, ASPIRIN, METOCLOPRAMIDE HYDROCHLORIDE, SALVIATHYMOL, BEPANTHEN. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5959466-8
Sorafenib side effect was reported by a Consumer or non-health professional from CANADA on Nov 11, 2008. Male patient, 67 years of age, weighting 116.8 lb, was diagnosed with neuroendocrine tumour, pain
and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dehydration, febrile neutropenia, mucosal inflammation, palmar-plantar erythrodysaesthesia syndrome. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, FENTANYL, MORPHINE. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5170903-1
Sorafenib side effect was reported by a Physician from FRANCE on Apr 19, 2006. Male patient, 75 years of age, weighting 163.1 lb, was diagnosed with metastatic renal cell carcinoma, hypertension, chronic obstructive pulmonary disease, abdominal pain upper, arthralgia, prophylaxis, insomnia, psoriasis and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: abdominal pain
, back pain
, conjunctivitis infective, dehydration, diarrhoea, fall
, haemoglobin decreased. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with BIPRETERAX, FLODIL LP, SYMBICORT, INIPOMP, EFFERALGAN, PRIMALAN, ZOLPIDEM TARTRATE, DIPROSALIC. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #4996191-4
Sorafenib side effect was reported by a Health Professional from FRANCE on Apr 19, 2006. Male patient, 74 years of age, weighting 163.1 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, fall
, haemoglobin decreased, renal failure acute. Sorafenib dosage: 800 MG, TOTAL DAILY, ORAL. During the same period patient was treated with BIPRETERAX, FLODIL, SYMBICORT, PANTOPRAZOLE, EFFERALGAN, PRIMALAN, STILNOX, DIPROSALIC. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5015809-3
Sorafenib side effect was reported by a Consumer or non-health professional from FRANCE on May 12, 2006. Male patient, 74 years of age, weighting 163.1 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: abdominal pain
, back pain
, conjunctivitis infective, dehydration, diarrhoea, fall
, haemoglobin decreased. Sorafenib dosage: 400 MG, BID; ORAL (SEE IMAGE). During the same period patient was treated with BIPRETERAX, FLODIL, SYMBICORT, PANTOPRAZOLE, EFFERALGAN, PRIMALAN, STILNOX, DIPROSALIC. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5050409-0
Sorafenib side effect was reported by a Consumer or non-health professional from POLAND on July 03, 2006. Male patient, 69 years of age, weighting 143.3 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dehydration, metabolic disorder
, multi-organ failure, respiratory failure. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with ISOSORBID MONONITRANS, METOPROLOL TARTRATE, ACETYLSALICYLIC ACID SRT, KETOPROFEN, TRAMADOL. Patient died on 12/16/2005.Sorafenib Side Effects Report #4907919-3
Sorafenib side effect was reported by a Health Professional from POLAND on Jan 31, 2006. Male patient, 69 years of age, weighting 143.3 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dehydration, respiratory failure. Sorafenib dosage: 400 MG BID ORAL. During the same period patient was treated with ISOSORBID MONONITRATE, METOPROLOL, ACETYLSALICYLIC ACID SRT, KETOPROFEN, TRAMADOL. Patient died on 12/16/2005.
Sorafenib Side Effects Report #4984228-8
Sorafenib side effect was reported by a Consumer or non-health professional from POLAND on Apr 13, 2006. Male patient, 69 years of age, weighting 143.3 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: abdominal mass, dehydration, malignant neoplasm progression, metabolic disorder
, metastatic renal cell carcinoma, multi-organ failure, respiratory failure, tumour necrosis. Sorafenib dosage: 400 MG, BID; ORAL. During the same period patient was treated with ISOSORBID MONONITRANS, METOPROLOL SUCCINATE, ACETYLSALICYLIC ACID SRT, KETOPROFEN, TRAMADOL. Patient died on 12/16/2005.Sorafenib Side Effects Report #5069422-2
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 31, 2006. Male patient, 68 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: alopecia, asthenia, dehydration, diverticulum, dysphagia, gastric haemorrhage, haematochezia, haemoglobin decreased. Sorafenib dosage: unknown. During the same period patient was treated with SYNTHROID, ZYRTEC, ZOLOFT, PRILOSEC, BENADRYL. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5074827-X
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on July 26, 2006. Male patient, 68 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: alopecia, dehydration, diverticulitis, dysphagia, gastrointestinal haemorrhage, intestinal perforation, malnutrition, nausea
. Sorafenib dosage: unknown. During the same period patient was treated with SYNTHROID, ZYRTEC, ZOLOFT, PRILOSEC, BENADRYL. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5106375-2
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 31, 2006. Male patient, 68 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: alopecia, asthenia, dehydration, dysphagia, gastric haemorrhage, haematochezia, haemoglobin decreased, intestinal perforation. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with SYNTHROID, ZYRTEC, ZOLOFT, PRILOSEC, BENADRYL. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5141124-3
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 31, 2006. Male patient, 68 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: alopecia, asthenia, dehydration, disease progression, diverticulum, dysphagia, gastric haemorrhage, gastrointestinal haemorrhage, haematochezia. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with SYNTHROID, ZYRTEC, ZOLOFT, PRILOSEC, BENADRYL. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5145855-0
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 31, 2006. Male patient, 68 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: alopecia, asthenia, dehydration, diverticulum, dysphagia, feeding tube complication, gastric haemorrhage, gastrointestinal disorder, gastrointestinal haemorrhage. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with SYNTHROID, ZYRTEC, ZOLOFT, PRILOSEC, BENADRYL. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5157117-6
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 31, 2006. Male patient, 68 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: alopecia, asthenia, dehydration, disease progression, diverticulitis, dysphagia, feeding tube complication, gastrointestinal haemorrhage. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with SYNTHROID, ZYRTEC, ZOLOFT, PRILOSEC, BENADRYL. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #4977059-6
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 31, 2006. Male patient, 68 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: alopecia, asthenia, dehydration, dysphagia, faeces discoloured, gastric haemorrhage, haematochezia, haemoglobin decreased. Sorafenib dosage: ORAL; 400 MG, BID, ORAL. During the same period patient was treated with SYNTHROID, ZYRTEC, ZOLOFT, PRILOSEC, BENADRYL. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #4880366-9
Sorafenib side effect was reported by a Physician from UNITED STATES on Dec 28, 2005. Female patient, 58 years of age, weighting 118.0 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood creatinine increased, blood glucose increased, blood urea increased, blood urea nitrogen/creatinine ratio increased, carbon dioxide decreased, dehydration, disease progression, hepatic failure. Sorafenib dosage: unknown. During the same period patient was treated with DITROPAN, EVISTA, HYZAAR. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5246575-4
Sorafenib side effect was reported by a Physician from UNITED STATES on Feb 12, 2007. Female patient, 56 years of age, weighting 123.5 lb, was diagnosed with metastatic renal cell carcinoma, insomnia, diarrhoea, nausea
and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, gastritis, metastatic renal cell carcinoma, renal failure. Sorafenib dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 200 MG. During the same period patient was treated with LUNESTA, PERCOCET, IMODIUM, COMPAZINE, ATIVAN. Patient was hospitalized. Patient died on 04/20/2006.Sorafenib Side Effects Report #5105584-6
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 05, 2006. Female patient, 56 years of age, weighting 123.5 lb, was diagnosed with metastatic renal cell carcinoma, insomnia, diarrhoea, nausea
and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: blood potassium decreased, blood pressure decreased, cardiomegaly, chest x-ray abnormal, colonic polyp
, culture stool positive, decubitus ulcer, dehydration, diarrhoea. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with LUNESTA, PERCOCET, IMODIUM, COMPAZINE, ATIVAN. Patient was hospitalized. Patient died on 04/20/2006.Sorafenib Side Effects Report #5133713-7
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 05, 2006. Female patient, 56 years of age, weighting 123.5 lb, was diagnosed with metastatic renal cell carcinoma, insomnia, diarrhoea, nausea
and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, gastritis, metastatic renal cell carcinoma, renal failure. Sorafenib dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 200 MG. During the same period patient was treated with LUNESTA, PERCOCET, IMODIUM, COMPAZINE, ATIVAN. Patient was hospitalized. Patient died on 04/20/2006.Sorafenib Side Effects Report #4888257-4
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 05, 2006. Female patient, 55 years of age, weighting 124.0 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: blood potassium decreased, cardiomegaly, chest x-ray abnormal, dehydration, diarrhoea, haemoglobin decreased, interstitial lung disease, oedema, renal failure. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with LUNESTA, PERCOCET, IMODIUM, COMPAZINE, ATIVAN. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #4901204-1
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 23, 2006. Female patient, 55 years of age, weighting 124.0 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: bacterial infection
, blood pressure decreased, colonic polyp
, culture stool positive, decubitus ulcer, dehydration, diarrhoea, gastritis, occult blood positive. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with LUNESTA, PERCOCET, IMODIUM, COMPAZINE, ATIVAN, DILAUDID, TAZIDIME. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #6061050-5
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 26, 2009. Female patient, 49 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: abdominal pain
, dehydration, diarrhoea, enterocolitis, hypotension, presyncope, retching. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with FENTANYL, SENNA, COLACE, OXYCODONE, LORAZEPAM, SYNTHROID. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5050101-2
Sorafenib side effect was reported by a Physician from UNITED STATES on June 29, 2006. Female patient, 47 years of age, weighting 132.3 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dehydration, enteritis, hypertension, nausea
, odynophagia, platelet disorder. Sorafenib dosage: 200 MG, BID, ORAL. During the same period patient was treated with COLACE, HYDROMORPHONE HYDROCHLORIDE, METHADONE, FENTANYL TRANSDERMAL SYSTEM. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5051735-1
Sorafenib side effect was reported by a Physician from UNITED STATES on June 30, 2006. Female patient, 47 years of age, weighting 132.3 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dehydration, enteritis, hypertension, nausea
, odynophagia, pain
, platelet disorder. Sorafenib dosage: 200 MG, BID, ORAL. During the same period patient was treated with COLACE, HYDROMORPHONE HYDROCHLORIDE, METHADONE, FENTANYL. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5122722-X
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 10, 2006. Female patient, 47 years of age, weighting 132.3 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dehydration, enteritis, hypertension, nausea
, odynophagia, platelet disorder. Sorafenib dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 200 MG. During the same period patient was treated with COLACE, HYDROMORPHONE HYDROCHLORIDE, METHADONE, FENTANYL. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5133648-X
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 10, 2006. Female patient, 47 years of age, weighting 132.3 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dehydration, enteritis, fatigue, hypertension, nausea
, odynophagia, platelet disorder. Sorafenib dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 200 MG. During the same period patient was treated with COLACE, HYDROMORPHONE HYDROCHLORIDE, METHADONE, FENTANYL. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5145824-0
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 10, 2006. Female patient, 47 years of age, weighting 132.3 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dehydration, enteritis, fatigue, hypertension, nausea
, odynophagia, platelet disorder. Sorafenib dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 200 MG. During the same period patient was treated with COLACE, HYDROMORPHONE HYDROCHLORIDE, METHADONE, FENTANYL CITRATE. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #4890808-0
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 13, 2006. Female patient, 47 years of age, weighting 132.3 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dehydration, enteritis, hypertension, odynophagia, platelet disorder. Sorafenib dosage: 200 MG, BID, ORAL. During the same period patient was treated with COLACE, HYDROMORPHONE HYDROCHLORIDE, METHADONE, FENTANYL. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5308186-1
Sorafenib side effect was reported by a Pharmacist from UNITED STATES on Apr 18, 2007. Male patient, 46 years of age, weighting 229.3 lb, was diagnosed with metastatic renal cell carcinoma, pain
, cancer pain, hypertension and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dehydration, encephalitis herpes, fall
, hydrocephalus
, mental status changes, metastases to meninges. Sorafenib dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 200 MG. During the same period patient was treated with OXYCODONE, NEURONTIN, DEXAMETHASONE, QUINAPRIL. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5114849-3
Sorafenib side effect was reported by a Physician from UNITED STATES on Feb 21, 2006. Male patient, 59 years of age, weighting 224.9 lb, was diagnosed with metastatic malignant melanoma, diabetes mellitus and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, hypotension, neutropenia. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with CARBOPLATIN, TAXOL, NOVOLOG, HUMULIN N, METFORMIN. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5143843-1
Sorafenib side effect was reported by a Physician from UNITED STATES on Feb 21, 2006. Male patient, 59 years of age, weighting 224.9 lb, was diagnosed with metastatic malignant melanoma, diabetes mellitus and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: asthenia, blood creatinine increased, blood sodium decreased, chills, dehydration, diarrhoea, dizziness
, haematocrit decreased, haemoglobin decreased. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with CARBOPLATIN, TAXOL, NOVOLOG, HUMULIN N, METFORMIN. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5158387-0
Sorafenib side effect was reported by a Physician from UNITED STATES on Feb 21, 2006. Male patient, 59 years of age, weighting 224.9 lb, was diagnosed with metastatic malignant melanoma, diabetes mellitus and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: anorexia, candidiasis, chills, dehydration, diarrhoea, haematocrit decreased, haemoglobin decreased, hypotension, nausea
. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with CARBOPLATIN, TAXOL, NOVOLOG, HUMULIN N, METFORMIN. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5176771-6
Sorafenib side effect was reported by a Physician from UNITED STATES on Feb 21, 2006. Male patient, 59 years of age, weighting 224.9 lb, was diagnosed with metastatic malignant melanoma, diabetes mellitus and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: anorexia, asthenia, blood creatinine increased, blood sodium decreased, dehydration, diarrhoea, dizziness
, haematocrit decreased, haemoglobin decreased. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with CARBOPLATIN, TAXOL, NOVOLOG, HUMULIN N, METFORMIN. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5612315-X
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 22, 2008. Male patient, 59 years of age, weighting 224.9 lb, was diagnosed with metastatic malignant melanoma, diabetes mellitus and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: asthenia, blood creatinine increased, blood sodium decreased, candidiasis, chills, dehydration, diarrhoea, dizziness
, haematocrit decreased. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with CARBOPLATIN, TAXOL, NOVOLOG, HUMULIN N, METFORMIN. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #4557147-9
Sorafenib side effect was reported by a Health Professional from on Jan 04, 2005. Male patient, 52 years of age, weighting 173.1 lb, was diagnosed with metastatic malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: blood bilirubin increased, chromaturia, dehydration, haemoglobin decreased, jaundice
, liver function test abnormal, pancreatic haemorrhage, pancreatitis, stent occlusion. Sorafenib dosage: 200 MG, BID, ORAL. During the same period patient was treated with DACARBAZINE, CHLORIDE, AUGMENTIN, PEPPERMINT WATER, NYSTATIN, CHLORHEXIDINE, MILPAR, TYLENOL. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #4634832-1
Sorafenib side effect was reported by a Health Professional from on Apr 05, 2005. Male patient, 52 years of age, weighting 173.1 lb, was diagnosed with metastatic malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: blood bilirubin increased, dehydration, gamma-glutamyltransferase increased, haemoglobin decreased, infection
, influenza like illness, malaise, metastases to pancreas, pancreatic haemorrhage. Sorafenib dosage: 200 MG, BID; ORAL. During the same period patient was treated with DACARBAZINE, CHLORIDE, AUGMENTIN, PEPPERMINT WATER, NYSTATIN, CHLORHEXIDINE, MILPAR, PARACETAMOL. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #4653392-2
Sorafenib side effect was reported by a Health Professional from on Apr 25, 2005. Male patient, 52 years of age, weighting 173.1 lb, was diagnosed with metastatic malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: bacterial infection
, cough, dehydration, haemoglobin decreased, influenza like illness, pancreatic carcinoma metastatic, pancreatic haemorrhage, pancreatitis, stent occlusion. Sorafenib dosage: 200 MG, BID, ORAL. During the same period patient was treated with DACARBAZINE, CHLORIDE, AUGMENTIN, PEPPERMINT WATER, NYSTATIN, CHLORHEXIDINE, MILPAR, PARACETAMOL. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #4634832-1
Sorafenib side effect was reported by a Health Professional from UNITED KINGDOM on Apr 05, 2005. Male patient, 52 years of age, weighting 173.1 lb, was diagnosed with metastatic malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: blood bilirubin increased, dehydration, gamma-glutamyltransferase increased, haemoglobin decreased, infection
, influenza like illness, malaise, metastases to pancreas, pancreatic haemorrhage. Sorafenib dosage: 200 MG, BID; ORAL. During the same period patient was treated with DACARBAZINE, CHLORIDE, AUGMENTIN, PEPPERMINT WATER, NYSTATIN, CHLORHEXIDINE, MILPAR, PARACETAMOL. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #4653392-2
Sorafenib side effect was reported by a Health Professional from UNITED KINGDOM on Apr 25, 2005. Male patient, 52 years of age, weighting 173.1 lb, was diagnosed with metastatic malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: bacterial infection
, cough, dehydration, haemoglobin decreased, influenza like illness, pancreatic carcinoma metastatic, pancreatic haemorrhage, pancreatitis, stent occlusion. Sorafenib dosage: 200 MG, BID, ORAL. During the same period patient was treated with DACARBAZINE, CHLORIDE, AUGMENTIN, PEPPERMINT WATER, NYSTATIN, CHLORHEXIDINE, MILPAR, PARACETAMOL. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #6130909-2
Sorafenib side effect was reported by a Physician from GERMANY on Mar 19, 2009. Male patient, 44 years of age, weighting 202.8 lb, was diagnosed with metastatic malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dehydration, hyperventilation, tachycardia, thrombocytopenia. Sorafenib dosage: unknown. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5932367-7
Sorafenib side effect was reported by a Health Professional from UNITED STATES on Oct 20, 2008. Female patient, 63 years of age, weighting 220.5 lb, was diagnosed with mesothelioma
, headache
, hypertension and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, grand mal convulsion, mental status changes, nausea
, subarachnoid haemorrhage. Sorafenib dosage: TOTAL DAILY DOSE: 200 MG UNIT DOSE: 200 MG. During the same period patient was treated with ADVIL, CARDIZEM, ZESTRIL, METHADONE, NEXIUM, DILTIAZEM, LISINOPRIL. Patient was hospitalized. Patient died on 03/22/2008.Sorafenib Side Effects Report #4962202-5
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 16, 2006. Male patient, 59 years of age, weighting 224.0 lb, was diagnosed with malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: anorexia, candidiasis, chills, dehydration, diarrhoea, haematocrit decreased, haemoglobin decreased, hypotension, malignant melanoma. Sorafenib dosage: 400 MG, BID, ORAL. During the same period patient was treated with CARBOPLATIN, TAXOL, NOVOLOG, HUMULIN N, METFORMIN, GLYBURIDE, METHADONE, GABAPENTIN. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5004567-4
Sorafenib side effect was reported by a Health Professional from UNITED STATES on May 04, 2006. Male patient, 59 years of age, weighting 224.0 lb, was diagnosed with malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: candidiasis, dehydration, diarrhoea, haematocrit decreased, haemoglobin decreased, hypotension, neutropenia, platelet count decreased, pyrexia. Sorafenib dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOL, NOVOLOG, HUMULIN N, METFORMIN, GLYBURIDE. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5008719-9
Sorafenib side effect was reported by a Physician from UNITED STATES on May 10, 2006. Male patient, 59 years of age, weighting 224.0 lb, was diagnosed with malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: anorexia, blood creatinine increased, candidiasis, chills, dehydration, diarrhoea, haematocrit decreased, haemoglobin decreased, nausea
. Sorafenib dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOL, NOVOLOG, HUMULIN N, METFORMIN, GLYBURIDE. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5836418-X
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 06, 2008. Female patient, 64 years of age, weighting 126.8 lb, was diagnosed with malignant hepatobiliary neoplasm and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: abdominal pain upper, catheter site cellulitis, culture wound positive, dehydration, glossodynia, incorrect dose administered, oral candidiasis, oral pain, skin candida. Sorafenib dosage: 200MG BID ORAL. During the same period patient was treated with OXALIPLATIN, XELODA, RANITIDINE, PREDNISONE, OXYCONTIN, OXYCODONE, WARFARIN, AMBIEN. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #6077015-3
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 10, 2009. Male patient, 76 years of age, weighting 158.7 lb, was diagnosed with lung neoplasm malignant and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: blood creatinine increased, dehydration, dysphagia, neutropenia, peripheral ischaemia, platelet count decreased. Sorafenib dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 200 MG. During the same period patient was treated with CISPLATIN, ETOPOSIDE, LISINOPRIL, HYTRIN. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #6088352-0
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 16, 2009. Male patient, 76 years of age, weighting 158.7 lb, was diagnosed with lung neoplasm malignant and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: arterial thrombosis, blood creatinine increased, dehydration, dysphagia, gastrointestinal haemorrhage, neutropenia, peripheral ischaemia, platelet count decreased. Sorafenib dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 200 MG. During the same period patient was treated with CISPLATIN, ETOPOSIDE, LISINOPRIL, HYTRIN. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #6101149-8
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 24, 2009. Male patient, 76 years of age, weighting 158.7 lb, was diagnosed with lung neoplasm malignant, arterial thrombosis and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: arterial thrombosis, blood creatinine increased, dehydration, dysphagia, neutropenia, peripheral ischaemia, platelet count decreased, rectal haemorrhage. Sorafenib dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 200 MG. During the same period patient was treated with CISPLATIN, ETOPOSIDE, ARIXTRA, LISINOPRIL, HYTRIN. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #6047926-3
Sorafenib side effect was reported by a Health Professional from UNITED STATES on Jan 14, 2009. Male patient, 68 years of age, weighting 167.6 lb, was diagnosed with hepatic neoplasm malignant non-resectable and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: ammonia increased, confusional state, dehydration, liver function test abnormal. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with BIOSPHERES, NADOLOL, AMLODIPINE BESYLATE, HYDROCHCHLOROTHIAZIDE, ASPIRIN, IBUPROFEN, PROTONIX, LACTULOSE. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5368784-6
Sorafenib side effect was reported by a Physician from UNITED KINGDOM on June 20, 2007. Male patient, 72 years of age, weighting 74.96 lb, was diagnosed with hepatic neoplasm malignant, dyspepsia, hyperlipidaemia, oedema, coronary artery disease
, hypertension, gout
and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, syncope. Sorafenib dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, PRAVASTATIN, FUROSEMIDE, METOPROLOL SUCCINATE, ASPIRIN, DIAVAN, ALLOPURINOL, TORSEMIDE. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5258530-9
Sorafenib side effect was reported by a Physician from CANADA on Feb 28, 2007. Male patient, 70 years of age, weighting 224.9 lb, was diagnosed with hepatic neoplasm malignant, gastrooesophageal reflux disease, pain
, hypercholesterolaemia, diabetes mellitus, hypertension, seasonal allergy and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: aortic valve stenosis, arteriovenous malformation
, atrial fibrillation
, bundle branch block left, dehydration, dilatation atrial, disease progression, electrocardiogram t wave abnormal, gastrointestinal haemorrhage. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with DOXORUBICIN, PROTONIX, OXYCONTIN, LIPITOR, ACTOS, HYDROCHLOROTHIAZIDE, LORATADINE. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5136997-4
Sorafenib side effect was reported by a Physician from CANADA on May 02, 2006. Male patient, 70 years of age, weighting 224.9 lb, was diagnosed with hepatic neoplasm malignant, gastrooesophageal reflux disease, pain
, hypercholesterolaemia, diabetes mellitus, atrial fibrillation
, hypertension and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: aortic valve stenosis, arteriovenous malformation
, atrial fibrillation
, dehydration, dilatation atrial, disease progression, gastrointestinal haemorrhage, hypercalcaemia, mitral valve stenosis. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with DOXORUBICIN, PROTONIX, OXYCONTIN, LIPITOR, ACTOS, TOPROL, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5164339-7
Sorafenib side effect was reported by a Physician from CANADA on May 02, 2006. Male patient, 70 years of age, weighting 224.9 lb, was diagnosed with hepatic neoplasm malignant, gastrooesophageal reflux disease, pain
, hypercholesterolaemia, diabetes mellitus, atrial fibrillation
, hypertension and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: aortic valve stenosis, arteriovenous malformation
, atrial fibrillation
, bundle branch block left, conduction disorder, dehydration, diastolic dysfunction, dilatation atrial, gastrointestinal haemorrhage. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with DOXORUBICIN, PROTONIX, OXYCONTIN, LIPITOR, ACTOS, TOPROL, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5226338-6
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 23, 2007. Male patient, 55 years of age, weighting 235.9 lb, was diagnosed with hepatic neoplasm malignant, barrett's oesophagus, thrombosis prophylaxis, hypertension, diabetes mellitus and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: anaemia, dehydration, ileus. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with DOXORUBICIN, ZANTAC, COUMADIN, VERAPAMIL, METFORMIN, XANAX. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5230173-2
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 29, 2007. Male patient, 55 years of age, weighting 235.9 lb, was diagnosed with hepatic neoplasm malignant, barrett's oesophagus, thrombosis prophylaxis, hypertension, diabetes mellitus and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: anaemia, dehydration, ileus. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with DOXORUBICIN, ZANTAC, COUMADIN, VERAPAMIL, METFORMIN. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5256351-4
Sorafenib side effect was reported by a Physician from UNITED STATES on Feb 27, 2007. Male patient, 55 years of age, weighting 235.9 lb, was diagnosed with hepatic neoplasm malignant, barrett's oesophagus, thrombosis prophylaxis, hypertension and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: anaemia, dehydration, ileus. Sorafenib dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 200 MG. During the same period patient was treated with DOXORUBICIN, ZANTAC, COUMADIN, VERAPAMIL. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5385563-4
Sorafenib side effect was reported by a Physician from UNITED KINGDOM on July 06, 2007. Male patient, 72 years of age, weighting 74.96 lb, was diagnosed with hepatic cancer metastatic, dyspepsia, hyperlipidaemia, oedema, coronary artery disease
, hypertension, gout
and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, syncope. Sorafenib dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, PRAVASTATIN, FUROSEMIDE, METOPROLOL SUCCINATE, ASPIRIN, DIOVAN, ALLOPURINOL, TORSEMIDE. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5400149-0
Sorafenib side effect was reported by a Physician from UNITED KINGDOM on July 24, 2007. Male patient, 72 years of age, weighting 74.96 lb, was diagnosed with hepatic cancer metastatic, dyspepsia, hyperlipidaemia, oedema, coronary artery disease
, hypertension, gout
and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: aortic stenosis, dehydration, diarrhoea, fall
, hepatic neoplasm malignant, hypokalaemia, hypotension, joint dislocation, malignant neoplasm progression. Sorafenib dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, PRAVASTATIN, FUROSEMIDE, METOPROLOL SUCCINATE, ASPIRIN, DIOVAN, ALLOPURINOL. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5447306-5
Sorafenib side effect was reported by a Physician from UNITED KINGDOM on Sept 05, 2007. Male patient, 72 years of age, weighting 163.1 lb, was diagnosed with hepatic cancer metastatic, dyspepsia, hyperlipidaemia, oedema, coronary artery disease
, hypertension, gout
and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, disease progression, syncope. Sorafenib dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, PRAVASTATIN, FUROSEMIDE, METOPROLOL SUCCINATE, ASPIRIN, DIOVAN, ALLOPURINOL. Patient was hospitalized. Patient died on 06/29/2007.Sorafenib Side Effects Report #5550715-7
Sorafenib side effect was reported by a Physician from GERMANY on Dec 06, 2007. Male patient, 72 years of age, weighting 163.1 lb, was diagnosed with hepatic cancer metastatic, dyspepsia, hyperlipidaemia, oedema, coronary artery disease
, hypertension, gout
and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: acute lymphocytic leukaemia, dehydration, diarrhoea, fatigue, syncope. Sorafenib dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, PRAVASTATIN, FUROSEMIDE, METOPROLOL SUCCINATE, ASPIRIN, DIOVAN, ALLOPURINOL. Patient was hospitalized. Patient died on 06/29/2007.Sorafenib Side Effects Report #5741526-8
Sorafenib side effect was reported by a Physician from GERMANY on Mar 31, 2008. Male patient, 72 years of age, weighting 163.1 lb, was diagnosed with hepatic cancer metastatic, dyspepsia, hyperlipidaemia, oedema, coronary artery disease
, hypertension, gout
and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: acute lymphocytic leukaemia, dehydration, diarrhoea, fatigue, syncope. Sorafenib dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, PRAVASTATIN, FUROSEMIDE, METOPROLOL SUCCINATE, ASPIRIN, DIOVAN, ALLOPURINOL. Patient was hospitalized. Patient died on 06/29/2007.Sorafenib Side Effects Report #5889106-8
Sorafenib side effect was reported by a Physician from GERMANY on Sept 17, 2008. Male patient, 72 years of age, weighting 163.1 lb, was diagnosed with hepatic cancer metastatic, dyspepsia, hyperlipidaemia, oedema, coronary artery disease
, hypertension, gout
and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, fatigue, hepatic neoplasm malignant, hypotension, joint dislocation, malignant neoplasm progression, oral candidiasis, syncope. Sorafenib dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, PRAVASTATIN, FUROSEMID, METOPROLOL SUCCINATE, ASPIRIN, DIOVAN, ALLOPURINOL. Patient was hospitalized. Patient died on 06/29/2007.Sorafenib Side Effects Report #5901560-1
Sorafenib side effect was reported by a Physician from GERMANY on Sept 25, 2008. Male patient, 72 years of age, weighting 163.1 lb, was diagnosed with hepatic cancer metastatic, dyspepsia, hyperlipidaemia, oedema, coronary artery disease
, hypertension, gout
and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: asthenia, dehydration, diarrhoea, fall
, fatigue, hepatic failure, hepatic neoplasm malignant, hypokalaemia. Sorafenib dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, PRAVASTATIN, FUROSEMID, METOPROLOL SUCCINATE, ASPIRIN, DIOVAN, ALLOPURINOL. Patient was hospitalized. Patient died on 06/29/2007.Sorafenib Side Effects Report #5586942-2
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 03, 2008. Male patient, 49 years of age, weighting 231.5 lb, was diagnosed with glioblastoma multiforme and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: deep vein thrombosis
, dehydration, dyspnoea, large intestine perforation, wound dehiscence. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with ERLOTINIB, DECADRON, PROVIGIL, KEPPRA, LASIX, ONDANSETRON, LOPERAMIDE. Patient was hospitalized. Patient died on 05/08/2007.Sorafenib Side Effects Report #5591259-6
Sorafenib side effect was reported by a Physician from UNITED STATES on Jan 03, 2008. Male patient, 49 years of age, weighting 231.5 lb, was diagnosed with glioblastoma multiforme and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: deep vein thrombosis
, dehydration, dyspnoea, large intestine perforation, wound dehiscence. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with ERLOTINIB, DECADRON, PROVIGIL, KEPPRA, LASIX, ONDANSETRON, LOPERAMIDE. Patient was hospitalized. Patient died on 05/08/2007.Sorafenib Side Effects Report #5602066-X
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 18, 2008. Male patient, 49 years of age, weighting 231.5 lb, was diagnosed with glioblastoma multiforme and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: deep vein thrombosis
, dehydration, disease progression, dyspnoea, failure to thrive, large intestine perforation, malaise, pneumatosis intestinalis. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with ERLOTINIB, DECADRON, PROVIGIL, KEPPRA, LASIX, ONDANSETRON, LOPERAMIDE. Patient was hospitalized. Patient died on 05/08/2007.Sorafenib Side Effects Report #6006056-7
Sorafenib side effect was reported by a Health Professional from UNITED STATES on Dec 04, 2008. Female patient, 62 years of age, weighting 310.9 lb, was diagnosed with breast cancer metastatic, arthritis
, hypertension, pruritus, pain
and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dehydration, renal failure. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with ABRAXANE, MOBIC, HYDROCHLOROTHIAZIDE, VISTARIL, LORTAB, CALCIUM. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5662398-6
Sorafenib side effect was reported by a Physician from FRANCE on Mar 10, 2008. Female patient, 52 years of age, was diagnosed with breast cancer metastatic and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: anorexia, asthenia, cognitive disorder, confusional state, dehydration, fall
. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with XELODA. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5823261-0
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on July 24, 2008. Female patient, 64 years of age, weighting 126.8 lb, was diagnosed with biliary neoplasm, neoplasm malignant and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dehydration, emotional distress, glossodynia, mucosal inflammation, pain
, tongue disorder. Sorafenib dosage: 200MG BID ORAL. During the same period patient was treated with OXALIPLATIN, RANITIDINE, PREDNISONE, OXYCONTIN, OXYCODONE, WARFARIN. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5248694-5
Sorafenib side effect was reported by a Physician from GERMANY on Feb 19, 2007. Male patient, 73 years of age, weighting 143.3 lb, was treated with Sorafenib. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, coma, confusional state, convulsion, dehydration. Sorafenib dosage: unknown. During the same period patient was treated with OXYGESIC, LISINOPRIL. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5129544-4
Sorafenib side effect was reported by a Physician from SWEDEN on Oct 11, 2006. Male patient, 72 years of age, weighting 229.3 lb, was diagnosed with arthritis
, paronychia, diarrhoea, haematemesis, blood potassium increased and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dehydration, dialysis
, diarrhoea, infection
, nausea
, renal failure. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with MODIFENAC, GLUCOSAMIN, PONDOCILLIN, IMODIUM, NEXIUM, GLUCOSIS CON. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5118383-6
Sorafenib side effect was reported by a Physician from FRANCE on Feb 17, 2006. Male patient, 71 years of age, weighting 198.4 lb, was diagnosed with convulsion prophylaxis, hypercholesterolaemia, thrombosis prophylaxis, hypertension and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: atrial flutter, dehydration, nausea
, performance status decreased, rash
, renal failure. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with NEURONTIN, KEPPRA, VASTEN, ASPIRIN, PERINDOPRIL ERBUMINE. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #4932681-8
Sorafenib side effect was reported by a Physician from FRANCE on Feb 17, 2006. Male patient, 70 years of age, weighting 198.4 lb, was treated with Sorafenib. After drug was administered, patient experienced the following side effects: atrial flutter, dehydration, diarrhoea, heart rate increased, renal failure. Sorafenib dosage: 400 MG BID ORAL; 200 MG BID ORAL, 200 MG QD ORAL. During the same period patient was treated with NEURONTIN, KEPPRA, VASTEN, KARDEGIC, COVERSYL, PRIMPERAN, CETIRIZINE. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5096109-2
Sorafenib side effect was reported by a Physician from FRANCE on Aug 25, 2006. Male patient, 69 years of age, weighting 165.3 lb, was diagnosed with renal failure, cardiac failure, hypercholesterolaemia, postoperative care and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, renal failure, weight decreased. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with KAYEXALATE, HEMIGOXINE, VASTEN, PREVISCAN. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5119203-6
Sorafenib side effect was reported by a Physician from FRANCE on Aug 25, 2006. Male patient, 69 years of age, weighting 165.3 lb, was diagnosed with renal failure, cardiac failure, hypercholesterolaemia and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, renal failure, weight decreased. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with KAYEXALATE, HEMIGOXINE, VASTEN. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5126726-2
Sorafenib side effect was reported by a Physician from FRANCE on Aug 25, 2006. Male patient, 69 years of age, weighting 165.3 lb, was diagnosed with renal failure, cardiac failure, hypercholesterolaemia and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, headache
, nausea
, renal failure, weight decreased. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with KAYEXALATE, HEMIGOXINE, VASTEN. Patient was hospitalized. Patient recovered.Sorafenib Side Effects Report #5397629-3
Sorafenib side effect was reported by a Physician from FRANCE on July 19, 2007. Male patient, 69 years of age, weighting 165.3 lb, was diagnosed with renal failure, cardiac failure, hypercholesterolaemia and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, headache
, renal failure. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with KAYEXALATE, DIGOXIN, PRAVASTATIN. Patient was hospitalized. Patient recovered.
Sorafenib and dehydration 